Page last updated: 2024-08-21

amiloride and Autosomal Dominant Juvenile Parkinson Disease

amiloride has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albinson, K; Arias, RL; Beyer, C; Bowlby, MR; Dunlop, J; Dwyer, JM; Kagan, N; Kubek, K; Lin, Q; Monaghan, M; Sung, ML; Vasylyev, D; Zaleska, MM; Zhang, MY	1

Other Studies

1 other study(ies) available for amiloride and Autosomal Dominant Juvenile Parkinson Disease

Article	Year
Amiloride is neuroprotective in an MPTP model of Parkinson's disease. Neurobiology of disease, 2008, Volume: 31, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acid Sensing Ion Channels; Acidosis, Lactic; Amiloride; Animals; Antiparkinson Agents; Binding, Competitive; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Peptides; Radioligand Assay; Sodium Channel Blockers; Sodium Channels; Spider Venoms; Substantia Nigra; Tyrosine 3-Monooxygenase	2008

Article

Year

Amiloride is neuroprotective in an MPTP model of Parkinson's disease.

Neurobiology of disease, 2008, Volume: 31, Issue:3

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acid Sensing Ion Channels; Acidosis, Lactic; Amiloride; Animals; Antiparkinson Agents; Binding, Competitive; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Peptides; Radioligand Assay; Sodium Channel Blockers; Sodium Channels; Spider Venoms; Substantia Nigra; Tyrosine 3-Monooxygenase

2008